Péter Galajda
Impact in
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Atrial Fibrillation Management and Outcomes 17
- Antiplatelet Therapy and Cardiovascular Diseases 11
-
- Renal Transplantation Outcomes and Treatments 11
- Co-authors
- Marian Mokáň (66 shared papers)Peter Kubisz (39 shared papers)Ján Staško (35 shared papers)Matej Samoš (42 shared papers)Tomáš Bolek (36 shared papers)Lucia Stančiaková (21 shared papers)Ingrid Škorňová (21 shared papers)František Kovář (14 shared papers)
- Journals
- American Journal of Therapeutics (4 papers)Journal of Cardiovascular Pharmacology (4 papers)Journal of Thrombosis and Thrombolysis (3 papers)Blood Coagulation & Fibrinolysis (3 papers)Pharmaceuticals (2 papers)
- Partner nations
- SlovakiaCanadaUnited Kingdom
In The Last Decade
Péter Galajda
72 papers receiving 586 citations
Peers
Comparison fields: 5 of 60
- Transplantation 46
- Internal Medicine 32
- Cardiology and Cardiovascular Medicine 225
- Hematology 86
- Endocrinology, Diabetes and Metabolism 65
Countries citing papers authored by Péter Galajda
This map shows the geographic impact of Péter Galajda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Galajda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Galajda more than expected).
Fields of papers citing papers by Péter Galajda
This network shows the impact of papers produced by Péter Galajda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Galajda. The network helps show where Péter Galajda may publish in the future.
Co-authors
The 25 scholars most cited alongside Péter Galajda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 40 | |
| 2 | 2008 | 35 | |
| 3 | 2009 | 35 | |
| 4 | 2017 | 33 | |
| 5 | 2014 | 29 | |
| 6 | Leptin, adiponectin and ghrelin, new potential mediators of ischemic stroke. | 2011 | 27 |
| 7 | 1997 | 26 | |
| 8 | HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia. | 2006 | 22 |
| 9 | 2021 | 17 | |
| 10 | 2019 | 15 | |
| 11 | 2019 | 14 | |
| 12 | 2018 | 13 | |
| 13 | 2015 | 12 | |
| 14 | 2018 | 12 | |
| 15 | 2018 | 12 | |
| 16 | 2018 | 12 | |
| 17 | 2007 | 11 | |
| 18 | 2016 | 11 | |
| 19 | 2017 | 11 | |
| 20 | 2003 | 9 |
About Péter Galajda
Péter Galajda is a scholar working on Cardiology and Cardiovascular Medicine, Transplantation, Hematology, Endocrinology, Diabetes and Metabolism and Nephrology, having authored 78 papers that have together received 610 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Renal Transplantation Outcomes and Treatments (11 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers), Platelet Disorders and Treatments (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). The work is most often cited by research in Transplantation (46 citations), Internal Medicine (32 citations), Cardiology and Cardiovascular Medicine (225 citations), Hematology (86 citations) and Endocrinology, Diabetes and Metabolism (65 citations). Péter Galajda has collaborated with scholars based in Slovakia, Canada and United Kingdom. Frequent co-authors include Marian Mokáň, Peter Kubisz, Ján Staško, Matej Samoš, Tomáš Bolek, Lucia Stančiaková, Ingrid Škorňová, František Kovář, Jela Ivanková and Ivana Dedinská. Their work appears in journals such as American Journal of Therapeutics, Journal of Cardiovascular Pharmacology, Journal of Thrombosis and Thrombolysis, Blood Coagulation & Fibrinolysis and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.